EGFR and neoplasm: By sequencing of LUAD cells harboring EGFR mutations, elevated expression of ELF3 was observed in advanced tumor cells, which promotes tumorigenesis through PI3K/AKT/NF-κB signaling pathway (He et al., 2021).